Kindly note that the deadline to register is June 3rd, 10 AM.

Hosted by EPSA USA for the FACC-NY community, this 45–50 minute session followed by Q&A will explore how French and Foreign companies operating in the U.S. can leverage R&D tax credits and recent changes to Section 174 to support growth, innovation, and cash flow.

The discussion will focus on practical considerations for cross-border businesses, including recent updates following the One Big Beautiful Bill Act (OBBBA) and what they mean for U.S. tax planning, compliance, and financial strategy.

Key Takeaways / Discussion Points:
• How French and European-owned companies can qualify for and document the U.S. R&D tax credit
• Key differences in qualifications between US R&D Credit and other European equivalents.
• What the repeal of Section 174 amortization means in practice, and what to do before June 30th 2026!
• Common challenges faced by cross-border companies when managing innovation and R&D investments.
• Concrete examples from U.S. and French innovative businesses
• Best practices to stay compliant while minimizing risk in a changing tax environment